SCHEMBL24176647

SCHEMBL24176647

O=[N+]([O-])c1ccc2c(c1)-c1nc3ncccn3c1CC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.50
KDM4E B2RXH2 4/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TDP1 Q9NUW8 2/20 0.40
IDO1 P14902 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
RXFP1 Q9HBX9 1/20 0.38
ROCK1 Q13464 1/20 0.37
PKM P14618 1/20 0.37
GAA P10253 2/20 0.35
KMT2A Q03164 3/20 0.35
POLB P06746 2/20 0.35
MEN1 O00255 2/20 0.35
MITF O75030 1/20 0.35
LMNA P02545 1/20 0.35
CASP6 P55212 1/20 0.35
HTR1A P08908 1/20 0.34
DRD1 P21728 1/20 0.34
RAB9A P51151 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL30277481 0.99 MAPT (0.49) MAPTKDM4EL3MBTL1NPSR1TDP1
SCHEMBL24177106 0.78 MAPT (0.46) MAPTKDM4EL3MBTL1NPSR1SMN1; SMN2
Bromide SCHEMBL30277449 0.77 MAPT (0.45) MAPTKDM4EL3MBTL1NPSR1SMN1; SMN2
SCHEMBL3118498 0.70 MAPT (0.55) MAPTKDM4EL3MBTL1NPSR1TDP1
SCHEMBL3126879 0.70 MAPT (0.55) MAPTKDM4EL3MBTL1NPSR1IDO1
Hydrochloric Acid SCHEMBL831427 0.69 MAPT (0.54) MAPTKDM4EL3MBTL1NPSR1IDO1
Hydrochloric Acid SCHEMBL834232 0.69 MAPT (0.54) MAPTKDM4EL3MBTL1NPSR1TDP1
SCHEMBL1872279 0.69 MAPT (0.51) MAPTKDM4EL3MBTL1NPSR1TDP1
SCHEMBL24176868 0.68 MAPT (0.71) MAPTKDM4EL3MBTL1NPSR1SMN1; SMN2
Bromide SCHEMBL30277607 0.68 MAPT (0.70) MAPTKDM4EL3MBTL1NPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11582970-B2 2-aminoimidazole-phenyl derivatives useful for controlling microbial growth NORTH CAROLINA STATE UNIVERSITY (US) 2023-02-21 US disclosed
US-20220000118-A1 2-AMINOIMIDAZOLE-PHENYL DERIVATIVES USEFUL FOR CONTROLLING MICROBIAL GROWTH NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2022-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11582970-B2 2-aminoimidazole-phenyl derivatives useful for controlling microbial growth DDC, IL4I1, ING2 MAPT 3880/4885KDM4E 571/4885L3MBTL1 3259/4885
US-20220000118-A1 2-AMINOIMIDAZOLE-PHENYL DERIVATIVES USEFUL FOR CONTROLLING MICROBIAL GROWTH DDC, IL4I1, ING2 MAPT 3880/4885KDM4E 571/4885L3MBTL1 3259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.